Nexalin Technology (NXL) Cash from Investing Activities (2023 - 2026)
Nexalin Technology's quarterly Cash from Investing Activities came in at $1.5 million in Q1 2026, up 2.44% year-on-year from $1.5 million in Q1 2025, and up 119.05% quarter-over-quarter from $689180.0 in Q4 2025.
Nexalin Technology has reported Cash from Investing Activities for 4 years, with the latest figure at $1.5 million in Q1 2026.
- For the quarter ending Q1 2026, Cash from Investing Activities rose 2.44% year-over-year to $1.5 million; the trailing twelve-month figure through Mar 2026 stood at -$96070.0 (down 157.56% YoY), and the FY2025 full-year result was -$131991.0, up 77.15% from the prior year.
- Cash from Investing Activities for Q1 2026 stood at $1.5 million, up from $689180.0 in the prior quarter.
- The five-year high for Cash from Investing Activities was $1.6 million in Q4 2024, with the low at -$4.5 million in Q3 2024.
- Average Cash from Investing Activities over 4 years is $404078.5, with a median of $1.2 million recorded in 2023.
- Year-over-year, Cash from Investing Activities tumbled 639.66% in 2024 and jumped 136.25% in 2025.
- Tracing NXL's Cash from Investing Activities over 4 years: stood at $1.2 million in 2023, then jumped by 33.09% to $1.6 million in 2024, then plunged by 57.66% to $689180.0 in 2025, then surged by 119.05% to $1.5 million in 2026.
- The last three Cash from Investing Activities figures came in at $1.5 million (Q1 2026), $689180.0 (Q4 2025), and $1.6 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -20.32 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | -185.00 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -816.00 Mn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | -591.00 Mn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -92.80 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -475.32 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | -298.50 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -2.50 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | -217.20 Mn |
| 10 | Nexalin Technology | 11.19 Mn | 8.48 Mn | 13,133.00 | 1.51 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.51 Mn |
| Mar 31, 2026 | 1.51 Mn |
| Dec 31, 2025 | 689,180.00 |
| Dec 31, 2025 | 689,180.00 |
| Sep 30, 2025 | 1.63 Mn |
| Sep 30, 2025 | 1.63 Mn |
| Jun 30, 2025 | -3.92 Mn |
| Jun 30, 2025 | -3.92 Mn |
| Mar 31, 2025 | 1.47 Mn |
| Mar 31, 2025 | 1.47 Mn |
| Dec 31, 2024 | 1.63 Mn |
| Dec 31, 2024 | 1.63 Mn |
| Sep 30, 2024 | -4.48 Mn |
| Sep 30, 2024 | -4.48 Mn |
| Jun 30, 2024 | 1.55 Mn |
| Jun 30, 2024 | 1.55 Mn |
| Mar 31, 2024 | 729,314.00 |
| Mar 31, 2024 | 729,314.00 |
| Dec 31, 2023 | 1.22 Mn |
| Dec 31, 2023 | 1.22 Mn |
| Sep 30, 2023 | 830,769.00 |
| Sep 30, 2023 | 830,769.00 |
| Jun 30, 2023 | 872,372.00 |
| Jun 30, 2023 | 872,372.00 |
| Mar 31, 2023 | 1.53 Mn |
| Mar 31, 2023 | 1.53 Mn |